-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Paratek Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2022.
- Paratek Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2023 was -$14.6M, a 17.4% increase year-over-year.
- Paratek Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2023 was -$62.7M, a 27% increase year-over-year.
- Paratek Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$63.6M, a 7.59% decline from 2021.
- Paratek Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$59.1M, a 38.8% increase from 2020.
- Paratek Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$96.5M, a 25% increase from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)